A higher incidence of colorectal cancer (CRC) is found in males compared to females.
Young women (18–44 years) with CRC have a better survival outcome compared to men of …

Colorectal cancer (CRC) is one of the most common causes of cancer morbidity in both
sexes but shows sex differences. First, sex-specific differences in tumor recurrence and …

Background Although estrogen (ERα/ERβ), progesterone (PGR), and androgen (AR)
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …

Background The mean incidence of ovarian metastases (OM) in patients with colorectal
cancer (CRC) is 3.4%. The 5-year survival of these patients, even when operated with …

Background Colorectal cancer is influenced by several factors such as unhealthy habits and
genetic factors. C1QB has been linked to a number of malignancies. However, uncertainty …

Abstract Background Sessile serrated adenomas (SSAs) are common polyps which give rise
to 20–30% of colorectal cancer (CRC). SSAs display clinicopathologic features which …

Background Several population-based studies and observational studies have shown that
oophorectomy is associated with an increased risk of colorectal cancer (CRC), and hormone …

Several epidemiological studies have reported that the use of female sex steroid hormones
could reduce the risk of colon cancer (CRC). This review summarizes the available data …

Colorectal cancer (CRC) is one of the most common causes of cancer morbidity in both male
and female. The development of CRC is found 1.5 times higher in men compared to women …

Irritable bowel syndrome (IBS) is characterized by repeated changes in the form of stool or
defecation habits with abdominal pain or discomfort. The prevalence of IBS is 7–24% among …